Literature DB >> 17428866

Hepatitis B virus X protein stimulates the mitochondrial translocation of Raf-1 via oxidative stress.

Jun Chen1, Aleem Siddiqui.   

Abstract

The human hepatitis B virus (HBV) X protein (HBx) plays a crucial role(s) in the viral life cycle and contributes to the onset of hepatocellular carcinoma (HCC). HBx caused the mitochondrial translocation of Raf-1 kinase either alone or in the context of whole-viral-genome transfections. Mitochondrial translocation of Raf-1 is mediated by HBx-induced oxidative stress and was dependent upon the phosphorylation of Raf-1 at the serine338/339 and Y340/341 residues by p21-activated protein kinase 1 and Src kinase, respectively. These studies provide an insight into the mechanisms by which HBV induces intracellular events relevant to liver disease pathogenesis, including HCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17428866      PMCID: PMC1900104          DOI: 10.1128/JVI.00172-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential.

Authors:  Z Rahmani; K W Huh; R Lasher; A Siddiqui
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 2.  Raf: a strategic target for therapeutic development against cancer.

Authors:  Muralidhar Beeram; Amita Patnaik; Eric K Rowinsky
Journal:  J Clin Oncol       Date:  2005-09-20       Impact factor: 44.544

3.  Calcium signaling by HBx protein in hepatitis B virus DNA replication.

Authors:  M J Bouchard; L H Wang; R J Schneider
Journal:  Science       Date:  2001-12-14       Impact factor: 47.728

4.  Intracellular localization of the hepatitis B virus HBx protein.

Authors:  Frank Henkler; Jonathan Hoare; Naushin Waseem; Robert D Goldin; Michael J McGarvey; Rajen Koshy; Ian A King
Journal:  J Gen Virol       Date:  2001-04       Impact factor: 3.891

5.  Enhancement of hepatitis B virus replication by its X protein in transgenic mice.

Authors:  Zhenming Xu; T S Benedict Yen; Lanying Wu; Charles R Madden; Wenjie Tan; Betty L Slagle; Jing-hsiung Ou
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

6.  Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress.

Authors:  G Waris; K W Huh; A Siddiqui
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

7.  The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338.

Authors:  A J King; H Sun; B Diaz; D Barnard; W Miao; S Bagrodia; M S Marshall
Journal:  Nature       Date:  1998-11-12       Impact factor: 49.962

8.  Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase.

Authors:  J R Fabian; I O Daar; D K Morrison
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

9.  Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells.

Authors:  Young Ik Lee; Jung Me Hwang; Jee Hye Im; Yoon Ik Lee; Nam Soon Kim; Dae Gon Kim; Dae Yeul Yu; Hyung Bae Moon; Sook Kyung Park
Journal:  J Biol Chem       Date:  2004-01-14       Impact factor: 5.157

Review 10.  HBV induced carcinogenesis.

Authors:  Delphine Cougot; Christine Neuveut; Marie Annick Buendia
Journal:  J Clin Virol       Date:  2005-12       Impact factor: 3.168

View more
  33 in total

Review 1.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

Review 2.  Oxidative stress and antioxidants in hepatic pathogenesis.

Authors:  Hye-Lin Ha; Hye-Jun Shin; Mark A Feitelson; Dae-Yeul Yu
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

3.  The effects of HBx gene on the expression of DNA repair enzymes hOGG1 and hMYHalpha mRNA in HepG2 cells.

Authors:  Bin Cheng; Xiaorong Guo; Yaochu Zheng; Ying Wang; Chunyan Liu; Peiyuan Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-04-28

Review 4.  Hepatocellular carcinoma and liver transplantation: clinical perspective on molecular targeted strategies.

Authors:  Yasunobu Matsuda; Takafumi Ichida; Manabu Fukumoto
Journal:  Med Mol Morphol       Date:  2011-09-16       Impact factor: 2.309

5.  Rotaviral enterotoxin nonstructural protein 4 targets mitochondria for activation of apoptosis during infection.

Authors:  Rahul Bhowmick; Umesh Chandra Halder; Shiladitya Chattopadhyay; Shampa Chanda; Satabdi Nandi; Parikshit Bagchi; Mukti Kant Nayak; Oishee Chakrabarti; Nobumichi Kobayashi; Mamta Chawla-Sarkar
Journal:  J Biol Chem       Date:  2012-08-10       Impact factor: 5.157

Review 6.  Rho'ing in and out of cells: viral interactions with Rho GTPase signaling.

Authors:  Céline Van den Broeke; Thary Jacob; Herman W Favoreel
Journal:  Small GTPases       Date:  2014-03-24

7.  Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib.

Authors:  Andrea L Inghilesi; Donatella Gallori; Lorenzo Antonuzzo; Paolo Forte; Daniela Tomcikova; Umberto Arena; Stefano Colagrande; Silvia Pradella; Bernardo Fani; Elena Gianni; Luca Boni; Giacomo Laffi; Francesco Di Costanzo; Fabio Marra
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

8.  HBx targeting to mitochondria and ROS generation are necessary but insufficient for HBV-induced cyclooxygenase-2 expression.

Authors:  Wonchung Lim; Soon-Hwan Kwon; Hyeseon Cho; Sujeong Kim; Seungmin Lee; Wang-Shick Ryu; Hyeseong Cho
Journal:  J Mol Med (Berl)       Date:  2009-11-26       Impact factor: 4.599

9.  AKT-mediated phosphorylation of ATG4B impairs mitochondrial activity and enhances the Warburg effect in hepatocellular carcinoma cells.

Authors:  Zhenhong Ni; Jintao He; Yaran Wu; Changjiang Hu; Xufang Dai; Xiaojing Yan; Bo Li; Xinzhe Li; Haojun Xiong; Yuming Li; Song Li; Liang Xu; Yongsheng Li; Jiqin Lian; Fengtian He
Journal:  Autophagy       Date:  2018-01-29       Impact factor: 16.016

10.  Sorafenib for the treatment of unresectable hepatocellular carcinoma.

Authors:  Junji Furuse
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.